Join Us
Join Us
Join Us
Back to top

Improving Access to New Medicines

Canadians wait too long – but we’re working to speed up the process.

Join Us

The Problem

Even after a treatment is approved by Health Canada, it can take more than two years before it becomes available through public drug plans. That’s significantly longer than in most peer countries, placing Canada last among G7 nations. In addition, fewer than 20 per cent of new medicines launched globally are available on Canadian public plans.

The Problem

Even after a treatment is approved by Health Canada, it can take more than two years before it becomes available through public drug plans. That’s significantly longer than in most peer countries, placing Canada last among G7 nations. In addition, fewer than 20 per cent of new medicines launched globally are available on Canadian public plans.

The Impact

The delayed availability of medicines and treatments comes at a real cost: 

Missed Opportunities

Canadians miss out on new treatments that could improve or save lives.

Fewer Options

Patients have fewer treatment options compared to those in other countries.

Less Investment

Canada becomes a less attractive destination for life sciences investments and clinical trials.

System Strain

The health system is further strained by outdated treatments.

Missed Opportunities

Canadians miss out on new treatments that could improve or save lives.

Fewer Options

Patients have fewer treatment options compared to those in other countries.

Less Investment

Canada becomes a less attractive destination for life sciences investments and clinical trials.

System Strain

The health system is further strained by outdated treatments.

The Solution

We believe Canadians deserve timely access to the best available treatments. We’re advocating for a smarter, more coordinated approach that includes: 

The Solution

We believe Canadians deserve timely access to the best available treatments. We’re advocating for a smarter, more coordinated approach that includes: 

1

Better collaboration between industry and government.

2

Modernized health technology assessment processes.

3

Systems that prioritize speed and patient outcomes.

4

Clearing regulatory backlogs.

Join the Community

Sign up below to help us build a stronger, healthier future for every Canadian.

By signing up, you agree to receive periodic emails from Medicine Matters Canada containing news, updates, and ways to get involved. Medicine Matters Canada is an initiative of Innovative Medicines Canada (“IMC”). These emails may be sent on IMC’s behalf by our service provider. You can unsubscribe at any time. Contact: Innovative Medicines Canada | 310-99 rue Bank St. Ottawa, ON K1P 6B9 | info@imc-mnc.ca

Learn more about Increasing Access to New Medicines

Waiting for New Medicines in Canada, Europe, and the United States

Learn more

Health Canada to Modernize Biologic Drug Submission

Learn more

Life on Hold – How Canada’s Drug Approval Delays Endanger Patients

Learn more